Keyphrases
2-Deoxy-d-glucose (2-DG)
100%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
33%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide Assay
33%
5-fluorouracil (5-FU)
66%
AIMS™
33%
Anaerobic Glycolysis
33%
Anticancer Therapy
33%
Apoptosis
33%
Breast Cancer Cells
100%
Breast Cancer Treatment
33%
Cancer Cell Death
33%
Cell Characteristics
33%
Cell Death
100%
Cell Viability
33%
Chemosensitizing Effect
100%
Cisplatin
66%
Cyclophosphamide
66%
Cytotoxic Effect
100%
DNA Damage
33%
Doxorubicin
66%
Glucose Analogues
33%
Glucose Metabolism
33%
Glucose Uptake
33%
Herceptin
66%
Malignancy
33%
Malignant Cells
33%
Metabolic Changes
33%
Mouse Embryonic Fibroblasts
33%
SKBR3
33%
Synergize
33%
Medicine and Dentistry
Anaerobic Glycolysis
25%
Breast Cancer
100%
Cancer
25%
Cancer Cell
100%
Cancer Therapy
25%
Cancer Treatment
25%
Cell Death
100%
Cell Line
50%
Cell Viability
25%
Cisplatin
50%
Cyclophosphamide
50%
Cytotoxicity
100%
Deoxyglucose
25%
DNA Damage
25%
Doxorubicin
50%
Fibroblast
25%
Fluorouracil
25%
Glucose
100%
Glucose Derivative
25%
Glucose Metabolism
25%
Glucose Uptake
25%
Mouse Embryo
25%
MTT Assay
25%
Programmed Cell Death
25%
Protein P53
25%
Trastuzumab
50%
Pharmacology, Toxicology and Pharmaceutical Science
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
25%
Breast Cancer
100%
Cell Viability
25%
Cisplatin
50%
Cyclophosphamide
50%
Cytotoxicity
100%
Deoxyglucose
25%
Doxorubicin
50%
Fluorouracil
25%
Glucose
100%
Glucose Derivative
25%
Protein P53
25%
Trastuzumab
50%
Nursing and Health Professions
Breast Cancer
100%
Cancer Therapy
25%
Chemotherapy
50%
Cisplatin
50%
Cyclophosphamide
50%
Deoxyglucose
25%
Doxil
50%
Fluorouracil
25%
Glucose
100%
Glucose Derivative
25%
Imaging
25%
MTT Assay
25%
Protein P53
25%
Trastuzumab
50%